AI-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary CTA
AI-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary CTA
Not yet recruiting · NCT06748261 · Registry updated 2024-12-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AI-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary CTA | Amyloid Neuropathies, Cardiomegaly, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, amyloidosis, aortic valve disorder, aortic valve stenosis, arrhythmogenic right ventricular cardiomyopathy, cardiomyopathy, cardiovascular disorder, congenital heart disease, dilated cardiomyopathy, disease, familial amyloid neuropathy, heart disorder, heart valve disorder, hereditary amyloidosis, hereditary disease, hypertrophic cardiomyopathy, inborn errors of metabolism, inherited neurodegenerative disorder, laminopathy, metabolic disease, myocarditis, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, proteostasis deficiencies, restrictive cardiomyopathy, subvalvular aortic stenosis | Not yet recruiting | Not stated | 2024-12-27 | NCT06748261 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Zhongshan Hospital | 347 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||